Stay updated with breaking news from Aematologic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Sickle cell disease, a group of inherited blood disorders, affects around 100,000 individuals in the United States and is predominant among African Americans.
New data emphasizes the value of MRD testing in predicting survival outcomes and informing the personalized treatment of patients with hematologic cancers clonoSEQ continues to be the MRD test of... | June 2, 2023
Syros Pharmaceuticals , a biopharmaceutical company committed to advancing new standards of care for the frontline treatment of hematologic malignancies, today announced the grant of restricted stock... | June 1, 2023
By Denny Jacob Blueprint Medicines on Monday said the Food and Drug Administration approved ayvakit as a treatment for adults with indolent systemic mastocytosis, a hematologic disorder that... | May 22, 2023
AOP Health announced new results on ropeginterferon alfa-2b (BESREMi®) from its clinical study CONTINUATION-PV in patients with polycythaemia vera (PV), a rare blood cancer. Professor Heinz Gisslinger